| Product Code: ETC6190836 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Severs disease, a common condition affecting children and adolescents, primarily occurs due to growth plate inflammation in the heel. In Australia, the treatment market for Severs disease includes a range of solutions, from physical therapy and pain management to orthopedic interventions. With the increasing awareness of the condition among parents, schools, and healthcare providers, the demand for effective treatment options is growing. Treatments often involve rest, stretches, ice therapy, and special footwear, though in some cases, more advanced interventions may be necessary. The market is driven by both medical practitioners efforts to offer early diagnosis and non-invasive therapies to alleviate symptoms.
The market for Severs disease treatments in Australia is influenced by an increase in awareness of childhood orthopedic conditions. Severs disease, also known as calcaneal apophysitis, is common in active children, especially those involved in sports. The rising focus on child health and sports participation is driving the demand for effective treatments, including orthotics, physical therapy, and anti-inflammatory medications. Additionally, there is an emphasis on early detection and prevention methods, such as improved footwear and stretching routines, contributing to the markets development. The growing healthcare infrastructure and access to specialized pediatric care further enhance the treatment options available for Severs disease in Australia.
Challenges in the Severs disease treatment market include underdiagnosis and low public awareness, especially among parents and coaches in youth sports. Treatment options are mostly supportive and non-pharmaceutical, limiting the scope for innovation and product differentiation. The lack of targeted therapies and standardized treatment protocols also restricts significant market development.
Severs disease, while common among active children and adolescents, remains under-addressed in Australia. Investment opportunities include the development of supportive footwear, orthotic solutions, physical therapy clinics with pediatric specialization, and awareness-focused digital platforms. Theres also space for innovation in wearable tech for early diagnosis and monitoring.
Policies within Australia`s healthcare framework indirectly support the Severs disease treatment market through broader initiatives on pediatric health and sports medicine. Medicare subsidies and the Pharmaceutical Benefits Scheme (PBS) ensure access to consultations and pain management therapies. The Therapeutic Goods Administration (TGA) regulates medications and orthotic devices used in treatment, maintaining quality and safety standards.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Severs Disease Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Severs Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Severs Disease Treatment Market - Industry Life Cycle |
3.4 Australia Severs Disease Treatment Market - Porter's Five Forces |
3.5 Australia Severs Disease Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Severs Disease Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Australia Severs Disease Treatment Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.8 Australia Severs Disease Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Severs Disease Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Australia Severs Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Severs Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Severs disease in Australia |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in the development of treatment options for Severs disease |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for treating Severs disease |
4.3.2 High treatment costs associated with advanced treatment options |
4.3.3 Stringent regulations and compliance requirements in the healthcare sector |
5 Australia Severs Disease Treatment Market Trends |
6 Australia Severs Disease Treatment Market, By Types |
6.1 Australia Severs Disease Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Severs Disease Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Severs Disease Treatment Market Revenues & Volume, By Acute, 2021- 2031F |
6.1.4 Australia Severs Disease Treatment Market Revenues & Volume, By Chronic, 2021- 2031F |
6.2 Australia Severs Disease Treatment Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Australia Severs Disease Treatment Market Revenues & Volume, By X-ray, 2021- 2031F |
6.2.3 Australia Severs Disease Treatment Market Revenues & Volume, By Squeeze Test, 2021- 2031F |
6.2.4 Australia Severs Disease Treatment Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.2.5 Australia Severs Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Severs Disease Treatment Market, By Dosage |
6.3.1 Overview and Analysis |
6.3.2 Australia Severs Disease Treatment Market Revenues & Volume, By Tablet, 2021- 2031F |
6.3.3 Australia Severs Disease Treatment Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 Australia Severs Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Severs Disease Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Severs Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Severs Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Australia Severs Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Severs Disease Treatment Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Severs Disease Treatment Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Australia Severs Disease Treatment Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Australia Severs Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Severs Disease Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Severs Disease Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Australia Severs Disease Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Australia Severs Disease Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Australia Severs Disease Treatment Market Import-Export Trade Statistics |
7.1 Australia Severs Disease Treatment Market Export to Major Countries |
7.2 Australia Severs Disease Treatment Market Imports from Major Countries |
8 Australia Severs Disease Treatment Market Key Performance Indicators |
8.1 Average age of diagnosis of Severs disease in Australia |
8.2 Percentage of healthcare facilities offering specialized treatment for Severs disease |
8.3 Number of research studies conducted on innovative treatment approaches for Severs disease |
9 Australia Severs Disease Treatment Market - Opportunity Assessment |
9.1 Australia Severs Disease Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Severs Disease Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Australia Severs Disease Treatment Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.4 Australia Severs Disease Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Severs Disease Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Australia Severs Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Severs Disease Treatment Market - Competitive Landscape |
10.1 Australia Severs Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Severs Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |